Dr. Lal Pathlabs has received approval from its Board to acquire immovable property situated in New Delhi. The company will enter into Agreement(s) with The South Indian Bank (the Mortgagee/ Lender) and other the Mortgagors/ Borrowers for the acquisition of the property. The company will pay consideration amount of up to Rs 74.51 crore (exclusive of Stamp Duty, Registration Fees, Brokerage/ Commission and other incidental expenses on actual basis). The property comprises four units situated at Plot No. Site-II, District Centre, Shalimar Palace, Shalimar Bagh, New Delhi.
Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.
